Appleton Partners Inc. MA Has $10.02 Million Position in iShares Biotechnology ETF (NASDAQ:IBB)

Appleton Partners Inc. MA boosted its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 0.1% in the fourth quarter, HoldingsChannel reports. The firm owned 75,803 shares of the financial services provider’s stock after buying an additional 104 shares during the period. Appleton Partners Inc. MA’s holdings in iShares Biotechnology ETF were worth $10,022,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. BNP Paribas Financial Markets raised its holdings in iShares Biotechnology ETF by 29.3% during the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after buying an additional 538,899 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its position in shares of iShares Biotechnology ETF by 32.9% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after acquiring an additional 164,000 shares in the last quarter. Aprio Wealth Management LLC acquired a new stake in shares of iShares Biotechnology ETF in the 4th quarter worth about $18,476,000. DRW Securities LLC bought a new position in iShares Biotechnology ETF in the 3rd quarter valued at about $5,990,000. Finally, Erste Asset Management GmbH acquired a new position in iShares Biotechnology ETF during the 3rd quarter valued at about $5,678,000. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Price Performance

Shares of IBB opened at $137.67 on Friday. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57. The stock has a 50 day moving average price of $136.22 and a two-hundred day moving average price of $141.41.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were given a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.